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Abstract
Background: Infrared thermal image scanners (ITIS) appear an attractive option for the mass screening of travellers for
influenza, but there are no published data on their performance in airports.
Methods: ITIS was used to measure cutaneous temperature in 1275 airline travellers who had agreed to tympanic
temperature measurement and respiratory sampling. The prediction by ITIS of tympanic temperature (37.8uC and 37.5uC)
and of influenza infection was assessed using Receiver Operating Characteristic (ROC) curves and estimated sensitivity,
specificity and positive predictive value (PPV).
Findings: Using front of face ITIS for prediction of tympanic temperature $37.8uC, the area under the ROC curve was 0.86
(95%CI 0.75–0.97) and setting sensitivity at 86% gave specificity of 71%. The PPV in this population of travellers, of whom
0.5% were febrile using this definition, was 1.5%. We identified influenza virus infection in 30 travellers (3 Type A and 27
Type B). For ITIS prediction of influenza infection the area under the ROC curve was 0.66 (0.56–0.75), a sensitivity of 87%
gave specificity of 39%, and PPV of 2.8%. None of the 30 influenza-positive travellers had tympanic temperature $37.8uCa t
screening (95%CI 0% to 12%); three had no influenza symptoms.
Conclusion: ITIS performed moderately well in detecting fever but in this study, during a seasonal epidemic of
predominantly influenza type B, the proportion of influenza-infected travellers who were febrile was low and ITIS were not
much better than chance at identifying travellers likely to be influenza-infected. Although febrile illness is more common in
influenza A infections than influenza B infections, many influenza A infections are afebrile. Our findings therefore suggest
that ITIS is unlikely to be effective for entry screening of travellers to detect influenza infection with the intention of
preventing entry of the virus into a country.
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Introduction
Rising concerns regarding Influenza A (H5N1) and the
pandemic of Influenza A (H1N1) 2009 have led to the use of
infrared thermal image scanners (ITIS) at some borders for the
mass screening of travellers to detect those who might be infected
with influenza [1]. ITIS measure body surface temperature
rapidly, non-invasively, and with no contact, minimising the risk
of contagion. They therefore have the potential to comply with the
International Health Regulations’ emphasis on containing the
spread of disease in ways that avoid unnecessary interference with
international traffic and trade [2].
Evaluations of the use of ITIS in clinical settings have been
conducted, and have reported sensitivities of 15% to 90% for
confirmed fever depending on the cut-off used to define fever
[3,4,5,6]. However, these findings may not be applicable to border
screening. ITIS measure body surface temperature, not body core
temperature, and so ITIS temperature measurements are subject
to the influence of a range of human and environmental factors.
These include whether a person is sunburnt, has taken antipyretics
or has circulatory problems, and also the ambient temperature and
humidity. Consequently it is important that the relationship
between body surface temperature and body core temperature be
evaluated within the environment in which ITIS are to be
operated.
In the airport setting, thermal scanning of arriving travellers has
been used to screen for several different infectious diseases. During
the outbreak of Severe Acute Respiratory Syndrome (SARS) ITIS
use was documented, however only the numbers of travellers
triggering the scanner were reported, without stating the cut-off
threshold used for fever or reporting on any subsequent method
used to confirm febrile status [7,8,9]. A trial dengue fever
screening programme found that among travellers arriving into
Cairns airport [10] 12% (118/963) of travellers who triggered the
pre-set alarm threshold were confirmed to be febrile on tympanic
temperature measurement. Influenza screening in Singapore
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e14490found that only 12% of cases of pandemic (H1N1) 2009 infection
with onset within 10 days of arrival were detected by ITIS on entry
[11].
Proper evaluation of a screening test requires that the ‘gold
standard’ test is applied to both test positive and test negative
participants in the study. To evaluate the use of ITIS in border
screening for influenza, its performance in predicting both fever
and also influenza infection is necessary. However to date no
studies have been reported that tested ITIS negative travellers for
either fever or influenza infection [12,13].
We undertook both ITIS and tympanic temperature measure-
ment on, and collected specimens for testing for influenza from,
symptomatic and asymptomatic air travellers arriving into
Christchurch, New Zealand during the Southern hemisphere
winter in 2008. This paper assesses the performance of ITIS in




This evaluation of thermal image scanning was carried out as
part of a larger study to measure the prevalence of seasonal
influenza infection in arriving airline travellers and the effective-
ness of a screening questionnaire for detecting those with influenza
infection. The design followed closely a pilot study carried out in
2007 [14].
Participants
Three airlines agreed to have their staff distribute a screening
questionnaire to travellers (passengers and crew) during flights
travelling from Australian airports to Christchurch, New Zea-
land. The questionnaires were collected by research assistants
following immigration processing on arrival in Christchurch.
‘Symptomatic’ travellers were defined as those who reported one
or more of the following symptoms: cough, sore throat, sneezing,
fever or chills, runny or blocked nose, muscle aches or
pains, feeling generally unwell, chest discomfort or breathing
difficulties.
Measures
Symptomatic travellers were all invited to have throat and nose
swabs (Copan Italia SPA, Brescia, Italy) taken and their
temperature measured. In addition, half the questionnaires were
marked and were randomly placed into the sets of questionnaires
delivered to the flight crew (the sequence was determined by the
RAND function of Microsoft Excel). Arriving travellers carrying
a marked questionnaire were also invited to have swabs and
temperature taken. The nurse taking the swabs noted on the
request form whether the traveller was symptomatic or asymp-
tomatic.
For the 23 working days from 21 August to 12 September 2008,
cutaneous temperature from those travellers invited to participate
who had given consent was measured using ITIS (Therma-
CAM
TM E45, FLIR Systems, Sweden) prior to swabs being taken.
A focal plane array (1606120 pixels) was used on the front of the
face and the side of the face (see Figure 1) and the maximum
temperature reading for each was recorded. After the swabs were
taken, each participant’s tympanic temperature was measured
using an infrared tympanic thermometer (ThermaScan PRO4000,
BRAUN, Germany).
The ambient temperature in the arrivals hall was a consistent
20.5uC at all times during data collection.
Laboratory Analysis
All nasal and throat swab samples were analysed at Canter-
bury Health Laboratories, Christchurch. A multiplexed tandem
polymerase chain reaction (MT-PCR) assay was employed to
detect the presence of influenza A and B virus infection, as
described by the manufacturer (Easy-Plex Influenza A+B kit, Cat.
No. 3005.01, AusDiagnostics Pty Ltd, Sydney, Australia).
Data Analysis
Stata 10 was used to analyse the data. The cii command was
used to calculate Poisson exact confidence intervals around the
proportion of influenza-infected travellers who were febrile.
Information about temperature measurements was collected on
the swab consent form and linked to the symptom information on
the questionnaire using a unique swab identifier. Nine swab results
were unable to be linked as their identifier had not been attached
to any questionnaire. For these individuals the nurse’s note of
whether or not they were symptomatic was used to define their
symptom status.
Analyses were performed to assess the accuracy of ITIS
measurements in predicting two different tympanic temperature
thresholds:
1. tympanic temperature $37.8uC( .100uF – the level used by
the Centers for Disease Control in defining ‘influenza-like
illness’) [15]
2. tympanic temperature $37.5uC (the threshold used in the
majority of reports) [12].
Firstly, a Receiver Operating Characteristic (ROC) curve [16]
was constructed. ROC curves assess the ability of a test (in this case
the ITIS measure) to discriminate between people who have, and
who do not have, a condition (fever). The area under the ROC
curve for an uninformative test is 0.5.
Secondly, a level of ITIS temperature with sensitivity closest to
85% was chosen and the specificity calculated.
Finally, the positive predictive value (PPV) of the chosen level of
ITIS temperature was estimated. The positive predictive value is
the proportion of people who test positive (i.e. are ‘positive’ on
ITIS) who actually have the condition of interest. It is not
appropriate to calculate the PPV of ITIS measures directly in this
sample since it was not a random sample of the population of
travellers but was instead ‘enriched’ by including as many
Figure 1. ITIS image of front of face.
doi:10.1371/journal.pone.0014490.g001
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samples. Therefore, the prevalence of fever (by each definition) in
the holders of marked questionnaires was combined with the
sensitivity and specificity of ITIS for detecting fever to estimate the
PPV in the population of all travellers who arrived on the flights
that took part in the study. To assess the utility of fever as a
screening test for influenza infection (MT-PCR result), sensitivity,
specificity, and population PPV for influenza were estimated for
each tympanic temperature threshold, and the ITIS threshold
used above.
Ethics
This study was approved by the New Zealand Health and
Disability Multiregion Ethics Committee. Written informed
consent was obtained from all participants.
Results
Participants
In total, 5274 travellers returned a questionnaire during the
study period, of whom 823 (15.6%) were symptomatic by our
definition. Figure 2 shows the pathway of potential participants
through the study.
Accuracy of thermal scanning in predicting core
temperature
Seven participants had a tympanic temperature of $37.8uC( 2
reported no symptoms and 5 were symptomatic). Five held marked
questionnaires, giving a prevalence of fever by this definition of
0.5% (5/1063). Half of the 38 participants with a tympanic
temperature of $37.5uC were symptomatic. Thirty-two of them
held a marked questionnaire, so the prevalence of fever by this
definition was 3.0% (32/1063).
Figure 3 is a ROC curve showing the ability of ITIS front of
face measurement to predict a tympanic temperature of $37.8uC.
Table 1 shows the test characteristics of ITIS as a predictor of
tympanic temperature. For each definition of ‘fever’ (determined
by tympanic temperature measurement), and for each site of ITIS
measurement (front and side of face), the table shows: the ITIS
threshold that gave a sensitivity closest to 85% in our data; the
proportion of travellers with an ITIS measure above that threshold
(i.e. who would have ‘triggered’ the ITIS during screening); the
area under the ROC curve; the actual sensitivity of that threshold;
and its specificity. The prevalence of fever at each threshold in
holders of marked questionnaires (as an estimate of the prevalence
in this population of arriving travellers) is also shown, as well as the
estimated PPV of ITIS for fever in this population.
Figure 2. Study flow chart showing how participants were selected from arrivals during the study period.
doi:10.1371/journal.pone.0014490.g002
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Of the 1275 respiratory samples obtained from participating
travellers, 30 were positive for influenza (3 Type A and 27 Type
B), while 7 samples were invalid as they contained no human
nucleic acid. The prevalence of influenza infection in holders of
marked questionnaires with valid samples was 1.9% (20/1057).
Most (90%; 27/30) influenza-positive participants were symp-
tomatic, but none (0%) had a measured tympanic temperature of
$37.8uC (99%CI 0% to 18%), and only two (7%) had a measured
tympanic temperature of $37.5uC(99%CI 0.3% to 31%). Table 2
shows the ability of tympanic and ITIS temperatures to predict
influenza infection in a population where the prevalence is 2% (the
estimate of the prevalence of infection in this population of
arriving travellers). With high sensitivity, specificity is very low.
Combined with the low prevalence of influenza infection in this
population, PPV is also very low.
Influenza-positive participants reported that the first of their
symptoms started between 12 hours and 24 days prior to
answering the questionnaire, with symptom duration of 2 days
or less in 11 participants, more than 2 and up to 5 days in 7
participants, and more than 5 days in 8 participants (3 were
asymptomatic and 1 did not respond to this question).
Discussion
The greatest potential for the use of ITIS to screen incoming or
departing travellers for infectious diseases such as a pandemic
strain of influenza would be as the first stage of screening; that is,
to identify and select out a high risk group for further assessment,
for example by questionnaire, body core temperature measure-
ment, and/or respiratory sample collection. This would require
very high sensitivity for raised body temperature, as any travellers
who ‘slipped through’ the screening process would enter the
community and potentially spread infection. In addition, core
temperature would need to be a good predictor of infection.
Can thermal scanning predict core temperature?
This study shows that, among a group comprising both
asymptomatic and symptomatic arriving international airline
travellers, ITIS can have moderately high sensitivity and specificity
for a high body core temperature of $37.8uC. However, the low
prevalence of fever in arriving travellers means that the PPV is
very low.
Does temperature predict infection?
Measurement of the sensitivity of fever for influenza infection
requires that afebrile as well as febrile people, from the same
population, are tested for influenza infection. There are few studies
that have done this, as symptoms of ‘influenza-like illness’, which
include fever, are usually criteria for entry to studies of influenza
[17,18,19]. Such studies, with selected participants with a high
prevalence of influenza infection, overestimate the sensitivity and
dramatically overestimate the PPV of fever for influenza infection
in unselected populations, such as airline travellers. A review of
volunteer challenge studies [20] showed that not only were
approximately 30% of influenza infections asymptomatic, but only
35% of those with symptoms had a measured fever .37.8uC. This
study found a lower prevalence of fever among the participants
infected with Influenza B (7/101) than with Influenza A
H1N1(88/285; 31%) [20].
In this study, none of the 30 travellers subsequently identified as
infected with influenza (most of whom had influenza B) had a
temperature $37.8uC, and only two had a temperature $37.5uC.
Figure 3. ROC curve of thermal scan vs tympanic temperature
$37.86C.
doi:10.1371/journal.pone.0014490.g003





















$37.8uC Front of face 35.9uC 29% 0.86 (0.75–0.97) 86% 71% 0.5% 1.5%
Side of face
{ 35.7uC 50% 0.76 (0.54–0.97) 86% 51% 0.9%
$37.5uC Front of face 35.4uC 62% 0.71 (0.62–0.81) 84% 39% 3.0% 4.1%
Side of face
{ 35.4uC 69% 0.67 (0.58–0.77) 84% 31% 3.6%
*These were chosen as the threshold with sensitivity closest to 85% in our data.
{in holders of marked questionnaires.
{One observation was excluded from these analyses, from an asymptomatic traveller with a tympanic temperature of 37.1 and front of face measure of 37.3 but a side of
face measure recorded as 40.1.
doi:10.1371/journal.pone.0014490.t001
Thermal Scanning for Influenza
PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e14490A tympanic temperature threshold of 36.2uC would be required to
identify a high proportion (87%; table 2) of influenza-infected
travellers. The ITIS temperature measures have better specificity
than this (non-febrile) level of tympanic temperature for identifying
influenza-infected travellers, but PPVs are all low at less than 3%.
The ROC result for influenza infection shows that ITIS on their
own are not much better than chance at identifying influenza-
infected travellers.
These results emphasise what is already known about fever as a
symptom of influenza – while it clearly is one of the symptoms that
can be experienced by people with influenza infection, it does not
occur in all infected people [20]. The prevalence of fever is high in
case series of patients with confirmed influenza infection [11,21],
since often one of the criteria that is often used to determine
whether testing takes place is the presence of fever. However,
where fever is not used as a criterion for influenza testing, the
prevalence of fever is by no means 100%, even among people with
severe symptoms. For example, among 106 patients hospitalised
with respiratory disease [22], 39% of those with confirmed
pandemic (H1N1) 2009 infection did not have a temperature of
$37.8uC at any time during admission. In this study, the
predominance of Influenza B infection may partly explain the low
prevalence of fever among infected participants (although the three
with Influenza A all had tympanic temperatures ,37.2uC ).Even
with more pyrexigenic strains, among travellers, who by de-
finition are not severely unwell and in fact who are mostly not
unwell at all, the proportion of influenza infected people who
are afebrile can be expected to be much higher than among
hospitalised patients [22] (because the sicker infected people
don’t travel), as shown in this study.
Limitations of this study
It was a condition of conducting this study that we did not delay
the transit of passengers through the airport by more than a few
minutes and, therefore, measurements had to be made efficiently.
We used a single measurement by an infrared tympanic
thermometer as our ‘gold standard’ measure of core temperature.
This approach may have introduced some random error into our
results, but is unlikely to have caused systematic bias and is likely to
be similar to the way that temperature would be confirmed in
practice. In addition, our participants sat still at approximately 1m
from the scanner for the ITIS measure and those who were
wearing glasses were asked to remove them, steps likely to have
provided greater accuracy than ITIS measures that are taken as
numerous people walk past a fixed scanner in an arrivals hall.
Therefore our study provides an assessment of the best results that
could be expected from the use of ITIS in border screening for
influenza.
In this study, no influenza-infected travellers had a measured
tympanic temperature $37.8uC. We do not believe that this was
because of systematic errors in tympanic temperature measure-
ments, as these were measured by trained nurses using standard
thermometers. We acknowledge that the number of infected
travellers was relatively small at 30 but the probability is only
0.005 (0.5%) that the prevalence of fever among the population of
infected travellers arriving from Australia into Christchurch at this
time was greater than 18%; in other words the vast majority of
infected travellers in this population were afebrile.
Among travellers, the proportion of influenza cases who are
febrile may be low because those infected with influenza that is
causing fever may feel too unwell to travel; 25% of travel-
associated cases of pandemic (H1N1) 2009 infection with onset in
Singapore were symptomatic on embarkation but the proportion
who were febrile was not reported [11]. In addition, it is possible
that unwell infected travellers had used anti-pyretics prior to or
during the flight, but this is a limitation of ITIS rather than of our
study. The study assessed the performance of ITIS in the real
world, which includes the fact that some unwell people take anti-
pyretics. Also, the flights that were part of this study were relatively
short – 3 to 4 hours – and it is possible that on longer flights some
of the infected travellers might have become febrile. However, it
remains unlikely that fever would occur in all, or even most,
infected travellers arriving at any international airport [23].
Good evidence on influenza virus transmissibility during the
various phases of viral infection, (including afebrile infection and
asymptomatic infection) is not available, but detection of viral
RNA on a respiratory sample does not necessarily mean that the
infected person is, or will be, infectious. We were not able to
perform culture for influenza virus in this study, so it is possible
that some of the infected travellers were not shedding viable virus.
Although the approximately one third of participants whose
symptoms were of 2 days’ duration or less were likely to be in the
early stages of their infection, those with longer duration of
symptoms may not have been. Unfortunately the symptoms of
influenza are so non-specific that it is difficult to estimate the stage
of influenza infection in a traveller with, for example, a cough that
has been present for several weeks. Nonetheless, it seems
reasonable to conclude that at least a third, and probably more,
of the infected (and afebrile) participants in this study were
infectious on or after arrival into New Zealand.
Implications
Influenza-infected arriving travellers include those who are
symptomatic (with or without fever), those who become symp-
tomatic during the flight, those who will develop symptoms
following arrival, and those who will never have symptoms. It is
not known whether the latter group are infectious, but clearly only
the first two categories could potentially be detected by entry
screening. Most people who were infected but asymptomatic on
boarding will still be asymptomatic on arrival at their destination







Estimated PPV for influenza
infection (in a population
with prevalence=2%)
Tympanic temperature 0.52 (0.40–0.63) 36.2uC 87% 11% 2.0%
ITIS front of face 0.66 (0.56–0.75) 35.4uC 87% 39% 2.8%
ITIS side of face 0.55 (0.45–0.65) 35.3uC 83% 24% 2.2%
*These were chosen as the threshold with sensitivity closest to 85% in our data.
doi:10.1371/journal.pone.0014490.t002
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H1N1 2009 pandemic, some countries decided to use ITIS in
entry screening with the hope that detecting travellers who were
febrile on arrival would be worthwhile to reduce the probability of
infected travellers entering the country, and that ITIS could detect
them [1]. This study provides evidence to the contrary.
The low PPV of ITIS measures for fever in this population
means that the number of false positives who would require further
investigation, presumably by taking a tympanic temperature,
would be very high. In this study, using a front of face ITIS
threshold of 35.4uC identifies 69% of travellers as requiring further
investigation, of whom only 4.1% had a tympanic temperature
$37.5uC. The PPV of any of the measures of temperature for
influenza infection itself was lower, at less than 3%. However, the
prevalence of disease is an important determinant of PPV, and the
prevalence of influenza infection in this study, performed during
the ‘influenza season’, was low at 1.9%. There are no other
published estimates of the prevalence of influenza in arriving
travellers, but it could be argued that the prevalence of infection
would be higher during a pandemic, which typically infects a
higher proportion of the population than seasonal influenza, than
in this study. On the other hand, particularly if local containment
strategies were in place in originating countries, the prevalence of
infection in travellers might be lower during a pandemic. At the
beginning of a pandemic, when effective entry screening would be
most useful, the prevalence of infection among travellers and
therefore the PPV will likely be much lower than the prevalence of
seasonal influenza in this study.
More importantly, raised temperature itself by any measure-
ment technology is insufficiently sensitive for influenza infection
for its measurement to be effective for mass screening in a
pandemic situation. Use of ITIS to identify travellers at high risk of
fever, measuring the core temperature of ITIS-positive travellers,
and then taking specimens from those with high core temperatures
would have failed to identify all the influenza-infected travellers in
this study. Using a lower temperature threshold (however
measured) for taking specimens could detect a high proportion
of influenza-infected travellers only by taking specimens from what
is likely to be an unfeasibly high proportion of travellers.
Governments may decide to implement entry screening,
including ITIS, for reasons other than to actually detect most
influenza-infected arrivals, for example to deter unwell people
from travelling, or to demonstrate to their citizens that they are
doing everything they can to protect population health. The risks
associated with this approach include the potentially very large
opportunity cost of further investigating ITIS ‘positive’ travellers,
including quarantine of those febrile on tympanic temperature
measurement pending specimen processing, and the potential for
the loss of public confidence in the pandemic response when it
becomes clear that many infected travellers were not detected by
the screening and entered the country.
Conclusion
In this study, during a seasonal epidemic of predominantly
influenza type B, influenza-infected arriving travellers had a very
low prevalence of fever. Consequently, ITIS would not have
identified influenza-infected travellers even though it performed
moderately well at detecting febrile travellers. Some aspects of this
study may not generalise to a pandemic of Influenza A. Although
febrile illness is more common in influenza A infections than
influenza B infections, many influenza A infections are afebrile.
Our findings therefore suggest that ITIS is unlikely to be effective
for entry screening of travellers to detect influenza infection with
the intention of preventing entry of the virus into a country.
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